カテゴリー： IMARC, 世界, 医療/バイオ

エアゾールデリバリー装置の世界市場2023-2028：産業動向、シェア、規模、成長、機会・予測

◆英語タイトル：Aerosol Delivery Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

IMARCが発行した調査報告書（IMARC23FB0111）◆商品コード：IMARC23FB0111
◆発行会社（リサーチ会社）：IMARC
◆発行日：2023年2月1日
◆ページ数：143
◆レポート形式：英語 / PDF
◆納品方法：Eメール
◆調査対象地域：グローバル
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single UserUSD2,999 ⇒換算￥449,850見積依頼/購入/質問フォーム
Five UserUSD3,999 ⇒換算￥599,850見積依頼/購入/質問フォーム
EnterprisewideUSD4,999 ⇒換算￥749,850見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

IMARC社の市場調査資料によると、2022年に444億ドルであった世界のエアゾールデリバリー装置市場規模は2028年に633億ドルまで拡大し、2023年から2028年の間にCAGR 5.4％増加すると見込まれています。当調査資料では、エアゾールデリバリー装置の世界市場について調査し、序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、製品別（ドライパウダー吸入器、定量吸入器、ネブライザー）分析、用途別（喘息、慢性閉塞性肺疾患（COPD）、嚢胞性線維症、非呼吸器系疾患）分析、地域別（北米、アジア太平洋、ヨーロッパ、中南米、中東・アフリカ）分析、SWOT分析、バリューチェーン分析、ファイブフォース分析、価格分析、競合状況など、以下の構成でまとめています。なお、当調査資料には、3M Company、Aerogen、GlaxoSmithKline plc、Johnson & Johnson、Koninklijke Philips N.V.、Merck & Co. Inc.、Metall Zug AG、Recipharm AB (publ)、Teva Pharmaceutical Industries Ltd. and Vectura Group plc.などの企業情報が含まれています。
・序論
・範囲・調査手法
・エグゼクティブサマリー
・イントロダクション
・世界のエアゾールデリバリー装置市場規模：製品別
- ドライパウダー吸入器の市場規模
- 定量吸入器の市場規模
- ネブライザーの市場規模
・世界のエアゾールデリバリー装置市場規模：用途別
- 喘息における市場規模
- 慢性閉塞性肺疾患（COPD）における市場規模
- 嚢胞性線維症における市場規模
- 非呼吸器系疾患における市場規模
・世界のエアゾールデリバリー装置市場規模：流通チャネル別
- 小売薬局チャネルの市場規模
- 病院薬局チャネルの市場規模
- オンラインストアチャネルの市場規模
・世界のエアゾールデリバリー装置市場規模：地域別
- 北米のエアゾールデリバリー装置市場規模
- アジア太平洋のエアゾールデリバリー装置市場規模
- ヨーロッパのエアゾールデリバリー装置市場規模
- 中南米のエアゾールデリバリー装置市場規模
- 中東・アフリカのエアゾールデリバリー装置市場規模
・SWOT分析
・バリューチェーン分析
・ファイブフォース分析
・価格分析
・競合状況

The global aerosol delivery devices market size reached US$ 44.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 63.3 Billion by 2028, exhibiting a growth rate (CAGR) of 5.4% during 2023-2028.

Aerosol delivery devices are used in drug delivery and treating respiratory disorders, such as asthma, obstructive lung diseases, cystic fibrosis, pulmonary arterial hypertension, infectious pulmonary. They lower dosage requirements, reduce systemic adverse effects and improve the ability of patients to self-administer medication. Some of the commonly available aerosol delivery devices are pressurized metered-dose inhalers, nebulizers, and valved holder chambers. At present, smart aerosol drug delivery devices are used in non-respiratory conditions, such as diabetes, analgesia, thyroid disorders, and genetic diseases, due to the advent of novel macromolecular medications.

Aerosol Delivery Devices Market Trends:
The global outbreak of the coronavirus disease (COVID-19) that leads to acute respiratory infections among patients represents one of the key factors driving the need for aerosol delivery devices. These devices assist in treating obstructive airway diseases at home and in healthcare settings. Apart from this, the rising prevalence of chronic respiratory infections due to surging air pollution levels, allergens and occupational risks, and the increasing number of individuals who smoke tobacco and drink is propelling the market growth. Moreover, a considerable rise in the geriatric population, which is more vulnerable to developing serious health illnesses, is positively influencing the demand for portable inhalation devices that are convenient and economical. Besides this, market players are developing novel aerosol delivery devices that help treat chronic inflammation and infection in the lungs and improve airway clearance in patients with cystic fibrosis (CF). Furthermore, they are offering mini ultrasonic nebulizers and inhalers through e-commerce channels that have automatic memory and are easy to use while traveling. This, in confluence with the escalating demand for personalized drug therapy and the increasing use of online channels for purchasing medical supplies, is driving the market.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global aerosol delivery devices market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, application and distribution channel.

Breakup by Product:

Dry Powder Inhalers
Single Dose Inhalers
Multi Dose Inhalers
Metered Dose Inhalers
Conventional Pressurized Inhalers
Soft Mist Inhalers
Nebulizers
Jet Nebulizers
Ultrasonic Wave Nebulizers
Vibrating Mesh Nebulizers

Breakup by Application:

Asthma
Chronic Obstructive Pulmonary Disease (COPD)
Cystic Fibrosis
Non-Respiratory Diseases
Diabetes
Analgesia
Parkinson’s Disease

Breakup by Distribution Channel:

Retail Pharmacies
Hospital Pharmacies
Online Stores

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, Aerogen, GlaxoSmithKline plc, Johnson & Johnson, Koninklijke Philips N.V., Merck & Co. Inc., Metall Zug AG, Recipharm AB (publ), Teva Pharmaceutical Industries Ltd. and Vectura Group plc.

Key Questions Answered in This Report
1. What was the size of the global aerosol delivery devices market in 2022?
2. What is the expected growth rate of the global aerosol delivery devices market during 2023-2028?
3. What are the key factors driving the global aerosol delivery devices market?
4. What has been the impact of COVID-19 on the global aerosol delivery devices market?
5. What is the breakup of the global aerosol delivery devices market based on the product?
6. What is the breakup of the global aerosol delivery devices market based on the distribution channel?
7. What are the key regions in the global aerosol delivery devices market?
8. Who are the key players/companies in the global aerosol delivery devices market?

❖ レポートの目次 ❖

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Aerosol Delivery Devices Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Dry Powder Inhalers
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Single Dose Inhalers
6.1.2.2 Multi Dose Inhalers
6.1.3 Market Forecast
6.2 Metered Dose Inhalers
6.2.1 Market Trends
6.2.2 Key Segments
6.2.2.1 Conventional Pressurized Inhalers
6.2.2.2 Soft Mist Inhalers
6.2.3 Market Forecast
6.3 Nebulizers
6.3.1 Market Trends
6.3.2 Key Segments
6.3.2.1 Jet Nebulizers
6.3.2.2 Ultrasonic Wave Nebulizers
6.3.2.3 Vibrating Mesh Nebulizers
6.3.3 Market Forecast
7 Market Breakup by Application
7.1 Asthma
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Chronic Obstructive Pulmonary Disease (COPD)
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Cystic Fibrosis
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Non-Respiratory Diseases
7.4.1 Market Trends
7.4.2 Key Segments
7.4.2.1 Diabetes
7.4.2.2 Analgesia
7.4.2.3 Parkinson’s Disease
7.4.3 Market Forecast
8 Market Breakup by Distribution Channel
8.1 Retail Pharmacies
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Hospital Pharmacies
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Online Stores
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 3M Company
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Aerogen
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 GlaxoSmithKline plc
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Johnson & Johnson
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Koninklijke Philips N.V.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 Merck & Co. Inc.
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Metall Zug AG
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.8 Recipharm AB (publ)
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.9 Teva Pharmaceutical Industries Ltd.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Vectura Group plc
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ エアゾールデリバリー装置の世界市場2023-2028：産業動向、シェア、規模、成長、機会・予測(Aerosol Delivery Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • COPD＆喘息用デバイスの世界市場2022-2028：産業動向、シェア、規模、成長、機会・予測
  • 喘息治療薬の世界市場2023～2028：産業動向、シェア、規模、成長、機会・予測
  • スマート吸入器の世界市場2023～2028：産業動向、シェア、規模、成長、機会・予測
  • デジタル定量吸入器の世界市場2023～2028：産業動向、シェア、規模、成長、機会・予測

    • ◆H&Iグローバルリサーチのお客様（例）◆